Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005681 | spliceosomal complex | 3 | 7 |
GO:0005684 | U2-type spliceosomal complex | 4 | 2 |
GO:0005686 | U2 snRNP | 5 | 2 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 7 |
GO:0071004 | U2-type prespliceosome | 5 | 2 |
GO:0071010 | prespliceosome | 4 | 2 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 2 |
GO:0097525 | spliceosomal snRNP complex | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0120114 | Sm-like protein family complex | 2 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 7 |
GO:1902494 | catalytic complex | 2 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 7 |
Related structures:
AlphaFold database: Q4QD88
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 7 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 7 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 7 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 8 |
GO:0006396 | RNA processing | 6 | 8 |
GO:0006397 | mRNA processing | 7 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 8 |
GO:0006807 | nitrogen compound metabolic process | 2 | 8 |
GO:0008152 | metabolic process | 1 | 8 |
GO:0008380 | RNA splicing | 7 | 7 |
GO:0009987 | cellular process | 1 | 8 |
GO:0016070 | RNA metabolic process | 5 | 8 |
GO:0016071 | mRNA metabolic process | 6 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 8 |
GO:0043170 | macromolecule metabolic process | 3 | 8 |
GO:0044237 | cellular metabolic process | 2 | 8 |
GO:0044238 | primary metabolic process | 2 | 8 |
GO:0045292 | mRNA cis splicing, via spliceosome | 9 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 8 |
GO:0071704 | organic substance metabolic process | 2 | 8 |
GO:0090304 | nucleic acid metabolic process | 4 | 8 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 8 |
GO:0003723 | RNA binding | 4 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 145 | 149 | PF00656 | 0.591 |
CLV_NRD_NRD_1 | 223 | 225 | PF00675 | 0.462 |
CLV_PCSK_KEX2_1 | 225 | 227 | PF00082 | 0.497 |
CLV_PCSK_PC1ET2_1 | 225 | 227 | PF00082 | 0.554 |
DOC_USP7_MATH_1 | 149 | 153 | PF00917 | 0.608 |
LIG_14-3-3_CanoR_1 | 156 | 164 | PF00244 | 0.672 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.658 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.605 |
LIG_FHA_2 | 163 | 169 | PF00498 | 0.568 |
LIG_FHA_2 | 22 | 28 | PF00498 | 0.479 |
LIG_IBAR_NPY_1 | 57 | 59 | PF08397 | 0.504 |
LIG_LIR_Gen_1 | 209 | 216 | PF02991 | 0.582 |
LIG_LIR_Nem_3 | 113 | 119 | PF02991 | 0.570 |
LIG_LIR_Nem_3 | 209 | 215 | PF02991 | 0.584 |
LIG_PCNA_yPIPBox_3 | 25 | 33 | PF02747 | 0.294 |
LIG_PTB_Apo_2 | 54 | 61 | PF02174 | 0.504 |
LIG_SH2_CRK | 73 | 77 | PF00017 | 0.457 |
LIG_SH2_NCK_1 | 4 | 8 | PF00017 | 0.601 |
LIG_SH2_SRC | 146 | 149 | PF00017 | 0.626 |
LIG_SH2_SRC | 181 | 184 | PF00017 | 0.642 |
LIG_SH2_STAP1 | 167 | 171 | PF00017 | 0.522 |
LIG_SH2_STAP1 | 212 | 216 | PF00017 | 0.565 |
LIG_SH2_STAT3 | 123 | 126 | PF00017 | 0.580 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.616 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.514 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.457 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.480 |
MOD_CK1_1 | 166 | 172 | PF00069 | 0.571 |
MOD_CK2_1 | 125 | 131 | PF00069 | 0.738 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.571 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.672 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.606 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.624 |
MOD_GlcNHglycan | 182 | 186 | PF01048 | 0.755 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.651 |
MOD_LATS_1 | 154 | 160 | PF00433 | 0.510 |
MOD_N-GLC_1 | 156 | 161 | PF02516 | 0.601 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.457 |
MOD_PIKK_1 | 99 | 105 | PF00454 | 0.598 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.549 |
MOD_Plk_2-3 | 142 | 148 | PF00069 | 0.591 |
MOD_Plk_2-3 | 163 | 169 | PF00069 | 0.502 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.657 |
TRG_ENDOCYTIC_2 | 212 | 215 | PF00928 | 0.594 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.457 |
TRG_ENDOCYTIC_2 | 73 | 76 | PF00928 | 0.371 |
TRG_ER_diArg_1 | 224 | 227 | PF00400 | 0.550 |
TRG_ER_diArg_1 | 50 | 53 | PF00400 | 0.512 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PET4 | Leptomonas seymouri | 51% | 100% |
A0A3S7WVH7 | Leishmania donovani | 94% | 100% |
A4HA73 | Leishmania braziliensis | 80% | 91% |
A4HYE5 | Leishmania infantum | 95% | 100% |
D0A0T0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 94% |
E9AS78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |